Familial pancreatic cancer and hereditary syndromes: Screening strategy for high-risk individuals

Journal of Gastroenterology

Volumn 46, Issue 11, 2011, Pages 1249-1259

  Matsubayashi, Hiroyuki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Family history; Hereditary syndrome; Pancreatic cancer; Risk factor; Screening

Indexed keywords

ADENOMATOUS POLYP; ADENOMATOUS POLYPOSIS COLI GENE; AUTOSOMAL DOMINANT DISORDER; BRCA2 GENE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CDKN2A GENE; EARLY CANCER; FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA SYNDROME; FAMILIAL CANCER; FAMILY HISTORY; GENETIC ASSOCIATION; HEREDITARY BREAST OVARIAN CANCER; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MUTATOR GENE; P16 GENE; PANCREAS CANCER; PANCREATITIS; PATIENT SELECTION; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; PRSS1 GENE; REVIEW; RISK ASSESSMENT; STK11 GENE;

CARCINOMA; EARLY DETECTION OF CANCER; GENETIC DISEASES, INBORN; HUMANS; PANCREATIC NEOPLASMS; RISK FACTORS;

EID: 84655169259     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-011-0457-z     Document Type: Review

References (117)

1. S Matsuno S Egawa S Fukuyama F Motoi M Sunamura S Isaji T Imaizumi S Okada H Kato K Suda A Nakao T Hiraoka R Hosotani K Takeda 2004 Pancreatic Cancer Registry in Japan: 20 years of experience Pancreas 28 219 230 (Pubitemid 38437313)
2. M Tada T Kawabe M Arizumi O Togawa S Matsubara N Yamamoto Y Nakai N Sasahira K Hirano T Tsujino K Tateishi H Isayama N Toda H Yoshida M Omata 2006 Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients Clin Gastroenterol Hepatol 4 1265 1270 (Pubitemid 44512221)
3. S Tanaka A Nakaizumi T Ioka O Oshikawa H Uehara M Nakao K Yamamoto O Ishikawa H Ohigashi T Kitamra 2002 Main pancreatic duct dilatation: a sign of high risk for pancreatic cancer Jpn J Clin Oncol 32 407 411 (Pubitemid 43102777)
4. S Tanno Y Nakano K Koizumi Y Sugiyama K Nakamura J Sasajima T Nishikawa Y Mizukami N Yanagawa T Fujii T Okumura T Obara Y Kohgo 2010 Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms Pancreas 39 36 40
5. T Shimosegawa K Kume K Satoh 2009 Chronic pancreatitis and pancreatic cancer: prediction and mechanism Clin Gastroenterol Hepatol 7 S23 S28
6. D Malka P Hammel F Maire P Rufat I Madeira F Pessione P Levy P Ruszniewski 2002 Risk of pancreatic adenocarcinoma in chronic pancreatitis Gut 51 849 852 (Pubitemid 35408607)
7. RH Hruban MI Canto M Goggins R Schulick AP Klein 2010 Update on familial pancreatic cancer Adv Surg 44 293 311
8. MI Canto 2007 Strategies for screening for pancreatic adenocarcinoma in high-risk patients Semin Oncol 34 295 302 (Pubitemid 47176623)
9. AP Klein KA Brune GM Petersen M Goggins AC Tersmette GJ Offerhaus C Griffin JL Cameron CJ Yeo S Kern RH Hruban 2004 Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds Cancer Res 64 2634 2638 (Pubitemid 38523922)
10. TA James DG Sheldon A Rajput BW Kuvshinoff MM Javle HR Nava JL Smith JF Gibbs 2004 Risk factors associated with earlier age of onset in familial pancreatic carcinoma Cancer 101 2722 2726 (Pubitemid 39603179)
11. HT Lynch CA Deters JF Lynch RE Brand 2004 Familial pancreatic carcinoma in Jews Fam Cancer 3 233 240
12. HT Lynch CA Deters CL Snyder JF Lynch P Villeneuve J Silberstein H Martin SA Narod RE Brand 2005 BRCA1 and pancreatic cancer: pedigree findings and their causal relationships Cancer Genet Cytogenet 158 119 125 (Pubitemid 40417693)
13. RR McWilliams KG Rabe C Olswold M De Andrade GM Petersen 2005 Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma Cancer 104 388 394 (Pubitemid 40993268)
14. ST Martin H Matsubayashi CD Rogers J Philips FJ Couch K Brune CJ Yeo SE Kern RH Hruban M Goggins 2005 Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer Oncogene 24 3652 3656 (Pubitemid 40756234)
15. H Rieder M Sina-Frey A Ziegler SA Hahn E Przypadlo R Kress B Gerdes M Colombo Benkmann T Eberl R Grutzmann M Lorken J Schmidt DK Bartsch 2002 German national case collection of familial pancreatic cancer-clinical-genetic analysis of the first 21 families Onkologie 25 262 266 (Pubitemid 34765273)
16. CD McFaul W Greenhalf J Earl N Howes JP Neoptolemos R Kress M Sina-Frey H Rieder S Hahn DK Bartsch 2006 Anticipation in familial pancreatic cancer Gut 55 252 258 (Pubitemid 43117286)
17. Matsubayashi H, Maeda A, Kanemoto H, Uesaka K, Yamazaki K, Hironaka S, Miyagi Y, Ikehara H, Ono H, Klein A, Goggins M. Risk factors of familial pancreatic cancer in Japan: current smoking and recent onset of diabetes. Pancreas. 2011;40:974-8.
18. RT Falk LW Pickle ET Fontham P Correa JF Fraumeni Jr 1988 Life-style risk factors for pancreatic cancer in Louisiana: a case-control study Am J Epidemiol 128 324 336
19. E Fernandez C La Vecchia B D'Avanzo E Negri S Franceschi 1994 Family history and the risk of liver, gallbladder, and pancreatic cancer Cancer Epidemiol Biomarkers Prev 3 209 212 (Pubitemid 24172532)
20. DT Silverman M Schiffman J Everhart A Goldstein KD Lillemoe GM Swanson AG Schwartz LM Brown RS Greenberg JB Schoenberg LM Pottern RN Hoover JF Fraumeni Jr 1999 Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer Br J Cancer 80 1830 1837 (Pubitemid 29389642)
21. M Schenk AG Schwartz E O'Neal M Kinnard JK Greenson JP Fryzek GS Ying DH Garabrant 2001 Familial risk of pancreatic cancer J Natl Cancer Inst 93 640 644 (Pubitemid 32409632)
22. P Ghadirian G Liu S Gallinger B Schmocker AJ Paradis G Lal JS Brunet WD Foulkes SA Narod 2002 Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas Int J Cancer 97 807 810 (Pubitemid 34106336)
23. M Inoue K Tajima T Takezaki N Hamajima K Hirose H Ito S Tominaga 2003 Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC) Int J Epidemiol 32 257 262 (Pubitemid 36622272)
24. MM Hassan ML Bondy RA Wolff JL Abbruzzese JN Vauthey PW Pisters DB Evans R Khan TH Chou R Lenzi L Jiao D Li 2007 Risk factors for pancreatic cancer: case-control study Am J Gastroenterol 102 2696 2707 (Pubitemid 350179330)
25. LN Anderson M Cotterchio S Gallinger 2009 Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada Cancer Causes Control 20 825 834
26. SS Coughlin EE Calle AV Patel MJ Thun 2000 Predictors of pancreatic cancer mortality among a large cohort of United States adults Cancer Causes Control 11 915 923 (Pubitemid 32005303)
27. K Hemminki X Li 2003 Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden Int J Cancer 103 525 530 (Pubitemid 36020229)
28. EJ Jacobs C Rodriguez CC Newton EB Bain AV Patel HS Feigelson MJ Thun EE Calle 2009 Family history of various cancers and pancreatic cancer mortality in a large cohort Cancer Causes Control 20 1261 1269
29. FM Giardiello JD Brensinger AC Tersmette SN Goodman GM Petersen SV Booker M Cruz-Correa JA Offerhaus 2000 Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 1447 1453 (Pubitemid 32198669)
30. DC Whitcomb S Applebaum SP Martin 1999 Hereditary pancreatitis and pancreatic carcinoma Ann N Y Acad Sci 880 201 209 (Pubitemid 29349128)
31. RP MacDermott P Kramer 1973 Adenocarcinoma of the pancreas in four siblings Gastroenterology 65 137 139
32. GM Petersen M de Andrade M Goggins RH Hruban M Bondy JF Korczak S Gallinger HT Lynch S Syngal KG Rabe D Seminara AP Klein 2006 Pancreatic cancer genetic epidemiology consortium Cancer Epidemiol Biomarkers Prev 15 704 710
33. TP Yeo RH Hruban J Brody K Brune S Fitzgerald CJ Yeo 2009 Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer J Gastrointest Surg 13 1487 1494
34. M Del Chiaro A Zerbi M Falconi L Bertacca M Polese N Sartori U Boggi G Casari BM Longoni R Salvia MA Caligo V Di Carlo P Pederzoli S Presciuttini F Mosca 2007 Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma Pancreatology 7 459 469 (Pubitemid 47587625)
35. KA Brune B Lau E Palmisano M Canto MG Goggins RH Hruban AP Klein 2010 Importance of age of onset in pancreatic cancer kindreds J Natl Cancer Inst 102 119 126
36. W Wang S Chen KA Brune RH Hruban G Parmigiani AP Klein 2007 PancPRO: risk assessment for individuals with a family history of pancreatic cancer J Clin Oncol 25 1417 1422 (Pubitemid 46706891)
37. Y Shimizu Y Kanemitsu T Sano Y Senda N Mizuno K Yamao 2010 A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm World J Surg 34 2932 2938
38. N Howes MM Lerch W Greenhalf DD Stocken I Ellis P Simon K Truninger R Ammann G Cavallini RM Charnley G Uomo M Delhaye J Spicak B Drumm J Jansen R Mountford DC Whitcomb JP Neoptolemos 2004 Clinical and genetic characteristics of hereditary pancreatitis in Europe Clin Gastroenterol Hepatol 2 252 261 (Pubitemid 38293313)
39. R Schneider EP Slater M Sina N Habbe V Fendrich E Matthai P Langer DK Bartsch 2011 German national case collection for familial pancreatic cancer (FaPaCa): ten years experience Fam Cancer 10 323 330
40. P Langer PH Kann V Fendrich N Habbe M Schneider M Sina EP Slater JT Heverhagen TM Gress M Rothmund DK Bartsch 2009 Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer Gut 58 1410 1418
41. K Brune T Abe M Canto L O'Malley AP Klein A Maitra N Volkan Adsay EK Fishman JL Cameron CJ Yeo SE Kern M Goggins RH Hruban 2006 Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer Am J Surg Pathol 30 1067 1076 (Pubitemid 44299338)
42. H Matsubayashi H Watanabe Y Ajioka K Nishikura M Yamano T Seki T Saito 2000 Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis Pancreas 21 77 85 (Pubitemid 30421938)
43. H Matsubayashi H Watanabe T Yamaguchi Y Ajioka K Nishikura M Iwafuchi M Yamano H Kijima T Saito 1999 Multiple K-ras mutations in hyperplasia and carcinoma in cases of human pancreatic carcinoma Jpn J Cancer Res 90 841 848 (Pubitemid 29431363)
44. C Shi AP Klein M Goggins A Maitra M Canto S Ali R Schulick E Palmisano RH Hruban 2009 Increased prevalence of precursor lesions in familial pancreatic cancer patients Clin Cancer Res 15 7737 7743
45. T Abe N Fukushima K Brune C Boehm N Sato H Matsubayashi M Canto GM Petersen RH Hruban M Goggins 2007 Genome-wide allelotypes of familial pancreatic adenocarcinomas and familial and sporadic intraductal papillary mucinous neoplasms Clin Cancer Res 13 6019 6025 (Pubitemid 350075057)
46. K Brune SM Hong A Li S Yachida T Abe M Griffith D Yang N Omura J Eshleman M Canto R Schulick AP Klein RH Hruban C Iacobuzio-Donohue M Goggins 2008 Genetic and epigenetic alterations of familial pancreatic cancers Cancer Epidemiol Biomarkers Prev 17 3536 3542
47. M Kopacova I Tacheci S Rejchrt J Bures 2009 Peutz-Jeghers syndrome: diagnostic and therapeutic approach World J Gastroenterol 15 5397 5408
48. E Volikos J Robinson K Aittomaki JP Mecklin H Jarvinen AM Westerman FW de Rooji T Vogel G Moeslein V Launonen IP Tomlinson AR Silver LA Aaltonen 2006 LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome J Med Genet 43 e18
49. H Rieder DK Bartsch 2004 Familial pancreatic cancer Fam Cancer 3 69 74 (Pubitemid 40655357)
50. N Sato C Rosty M Jansen N Fukushima T Ueki CJ Yeo JL Cameron CA Iacobuzio-Donahue RH Hruban M Goggins 2001 STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas Am J Pathol 159 2017 2022 (Pubitemid 33104257)
51. F Sahin A Maitra P Argani N Sato N Maehara E Montgomery M Goggins RH Hruban GH Su 2003 Loss of Stk11/Lkb1 expression in pancreatic and biliary neoplasms Mod Pathol 16 686 691 (Pubitemid 36871502)
52. MI Canto M Goggins CJ Yeo C Griffin JE Axilbund K Brune SZ Ali S Jagannath GM Petersen EK Fishman S Piantadosi FM Giardiello RH Hruban 2004 Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach Clin Gastroenterol Hepatol 2 606 621 (Pubitemid 38834045)
53. M Tanaka S Chari V Adsay C Fernandez-del Castillo M Falconi M Shimizu K Yamaguchi K Yamao S Matsuno 2006 International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas Pancreatology 6 17 32
54. L Le Bodic M Schnee T Georgelin F Soulard C Ferec JD Bignon M Sagniez 1996 An exceptional genealogy for hereditary chronic pancreatitis Dig Dis Sci 41 1504 1510 (Pubitemid 26245936)
55. C Le Marechal E Masson JM Chen F Morel P Ruszniewski P Levy C Ferec 2006 Hereditary pancreatitis caused by triplication of the trypsinogen locus Nat Genet 38 1372 1374 (Pubitemid 44837557)
56. DC Whitcomb MC Gorry RA Preston W Furey MJ Sossenheimer CD Ulrich SP Martin LK Gates Jr ST Amann PP Toskes R Liddle K McGrath G Uomo JC Post GD Ehrlich 1996 Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene Nat Genet 14 141 145 (Pubitemid 26338792)
57. N Teich J Rosendahl M Toth J Mossner M Sahin-Toth 2006 Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis Hum Mutat 27 721 730 (Pubitemid 44205064)
58. M Sahin-Toth M Toth 2000 Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen Biochem Biophys Res Commun 278 286 289
59. E Kereszturi R Szmola Z Kukor P Simon FU Weiss MM Lerch M Sahin-Toth 2009 Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism Hum Mutat 30 575 582
60. AB Lowenfels P Maisonneuve EP DiMagno Y Elitsur LK Gates Jr J Perrault DC Whitcomb 1997 Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group J Natl Cancer Inst 89 442 446 (Pubitemid 27136736)
61. V Rebours MC Boutron-Ruault M Schnee C Ferec F Maire P Hammel P Ruszniewski P Levy 2008 Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series Am J Gastroenterol 103 111 119
62. V Rebours P Levy JF Mosnier JY Scoazec MS Soubeyrand JF Flejou B Turlin P Hammel P Ruszniewski P Bedossa A Couvelard 2010 Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis Clin Gastroenterol Hepatol 8 206 212
63. N Malats T Casals M Porta L Guarner X Estivill FX Real 2001 Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group Gut 48 70 74 (Pubitemid 32042644)
64. H Matsubayashi N Fukushima N Sato K Brune M Canto CJ Yeo RH Hruban SE Kern M Goggins 2003 Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer Cancer Biol Ther 2 652 655
65. R Pezzilli AM Morselli-Labate V Mantovani E Romboli P Selva M Migliori R Corinaldesi L Gullo 2003 Mutations of the CFTR gene in pancreatic disease Pancreas 27 332 336 (Pubitemid 37337900)
66. A Masamune K Kume T Shimosegawa 2007 Differential roles of the SPINK1 gene mutations in alcoholic and nonalcoholic chronic pancreatitis J Gastroenterol 42 Suppl 17 135 140 (Pubitemid 46140381)
67. N Teich HU Schulz H Witt M Bohmig V Keim 2003 N34S, a pancreatitis associated SPINK1 mutation, is not associated with sporadic pancreatic cancer Pancreatology 3 67 68 (Pubitemid 36351181)
68. AB Lowenfels P Maisonneuve DC Whitcomb MM Lerch EP DiMagno 2001 Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis JAMA 286 169 170 (Pubitemid 32640846)
69. W Bergman P Watson J de Jong HT Lynch RM Fusaro 1990 Systemic cancer and the FAMMM syndrome Br J Cancer 61 932 936 (Pubitemid 20197009)
70. HT Lynch RM Fusaro JF Lynch R Brand 2008 Pancreatic cancer and the FAMMM syndrome Fam Cancer 7 103 112
71. T Takenouchi M Ito 1995 Familial malignant melanoma Nippon Rinsho 53 2754 2758
72. LA Cannon-Albright LJ Meyer DE Goldgar CM Lewis WP McWhorter M Jost D Harrison DE Anderson JJ Zone MH Skolnick 1994 Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM) Cancer Res 54 6041 6044 (Pubitemid 24378624)
73. AM Goldstein M Chan M Harland EM Gillanders NK Hayward MF Avril E Azizi G Bianchi-Scarra DT Bishop B Bressac-de Paillerets W Bruno D Calista LA Cannon Albright F Demenais DE Elder P Ghiorzo NA Gruis J Hansson D Hogg EA Holland PA Kanetsky RF Kefford MT Landi J Lang SA Leachman RM Mackie V Magnusson GJ Mann K Niendorf J Newton Bishop JM Palmer S Puig JA Puig-Butille FA de Snoo M Stark H Tsao MA Tucker L Whitaker E Yakobson 2006 High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL Cancer Res 66 9818 9828 (Pubitemid 44672032)
74. HT Lynch RE Brand D Hogg CA Deters RM Fusaro JF Lynch L Liu J Knezetic NJ Lassam M Goggins S Kern 2002 Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome Cancer 94 84 96 (Pubitemid 34049045)
75. Rutter JL, Bromley CM, Goldstein AM, Elder DE, Holly EA, Guerry Dt, Hartge P, Struewing JP, Hogg D, Halpern A, Sagebiel RW, Tucker MA. Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study. Cancer. 2004;101:2809-16. (Pubitemid 39603189)
76. HF Vasen NA Gruis RR Frants PA van Der Velden ET Hille W Bergman 2000 Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden) Int J Cancer 87 809 811 (Pubitemid 30660559)
77. N Ikeda Y Miyoshi K Yoneda E Shiba Y Sekihara M Kinoshita S Noguchi 2001 Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families Int J Cancer 91 83 88
78. M Sekine H Nagata S Tsuji Y Hirai S Fujimoto M Hatae I Kobayashi T Fujii I Nagata K Ushijima K Obata M Suzuki M Yoshinaga N Umesaki S Satoh T Enomoto S Motoyama K Tanaka 2001 Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population Clin Cancer Res 7 3144 3150 (Pubitemid 32963837)
79. JL Berliner AM Fay 2007 Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors J Genet Couns 16 241 260 (Pubitemid 46878636)
80. MS Brose TR Rebbeck KA Calzone JE Stopfer KL Nathanson BL Weber 2002 Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program J Natl Cancer Inst 94 1365 1372 (Pubitemid 35154141)
81. R Moslehi W Chu B Karlan D Fishman H Risch A Fields D Smotkin Y Ben-David J Rosenblatt D Russo P Schwartz N Tung E Warner B Rosen J Friedman JS Brunet SA Narod 2000 BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer Am J Hum Genet 66 1259 1272 (Pubitemid 30468783)
82. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst. 1999;91:1310-6.
83. EP Slater P Langer V Fendrich N Habbe B Chaloupka E Matthai M Sina SA Hahn DK Bartsch 2010 Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families Fam Cancer 9 335 343
84. FJ Couch MR Johnson KG Rabe K Brune M de Andrade M Goggins H Rothenmund S Gallinger A Klein GM Petersen RH Hruban 2007 The prevalence of BRCA2 mutations in familial pancreatic cancer Cancer Epidemiol Biomarkers Prev 16 342 346 (Pubitemid 46383356)
85. M Goggins M Schutte J Lu CA Moskaluk CL Weinstein GM Petersen CJ Yeo CE Jackson HT Lynch RH Hruban SE Kern 1996 Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas Cancer Res 56 5360 5364 (Pubitemid 27011364)
86. KM Murphy KA Brune C Griffin JE Sollenberger GM Petersen R Bansal RH Hruban SE Kern 2002 Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17% Cancer Res 62 3789 3793 (Pubitemid 34728862)
87. A Figer L Irmin R Geva D Flex J Sulkes A Sulkes E Friedman 2001 The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel Br J Cancer 84 478 481 (Pubitemid 32215873)
88. F Skoulidis LD Cassidy V Pisupati JG Jonasson H Bjarnason JE Eyfjord FA Karreth M Lim LM Barber SA Clatworthy SE Davies KP Olive DA Tuveson AR Venkitaraman 2010 Germline Brca2 heterozygosity promotes Kras(G12D)-driven carcinogenesis in a murine model of familial pancreatic cancer Cancer Cell 18 499 509
89. KW Jasperson TM Tuohy DW Neklason RW Burt 2010 Hereditary and familial colon cancer Gastroenterology 138 2044 2058
90. HT Lynch GJ Voorhees SJ Lanspa PS McGreevy JF Lynch 1985 Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study Br J Cancer 52 271 273 (Pubitemid 15229364)
91. M Aarnio R Sankila E Pukkala R Salovaara LA Aaltonen A de la Chapelle P Peltomaki JP Mecklin HJ Jarvinen 1999 Cancer risk in mutation carriers of DNA-mismatch-repair genes Int J Cancer 81 214 218 (Pubitemid 29144749)
92. RE Wilentz M Goggins M Redston VA Marcus NV Adsay TA Sohn SS Kadkol CJ Yeo M Choti M Zahurak K Johnson M Tascilar GJ Offerhaus RH Hruban SE Kern 2000 Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity Am J Pathol 156 1641 1651 (Pubitemid 30646702)
93. N Banville R Geraghty E Fox DT Leahy A Green D Keegan J Geoghegan D O'Donoghue J Hyland K Sheahan 2006 Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene Hum Pathol 37 1498 1502 (Pubitemid 44584335)
94. B Nakata YQ Wang M Yashiro N Nishioka H Tanaka M Ohira T Ishikawa H Nishino K Hirakawa 2002 Prognostic value of microsatellite instability in resectable pancreatic cancer Clin Cancer Res 8 2536 2540 (Pubitemid 34856337)
95. FM Giardiello GJ Offerhaus DH Lee AJ Krush AC Tersmette SV Booker NC Kelley SR Hamilton 1993 Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis Gut 34 1394 1396 (Pubitemid 23293626)
96. F Maire P Hammel B Terris S Olschwang D O'Toole A Sauvanet L Palazzo P Ponsot B Laplane P Levy P Ruszniewski 2002 Intraductal papillary and mucinous pancreatic tumour: a new extracolonic tumour in familial adenomatous polyposis Gut 51 446 449
97. SC Abraham TT Wu DS Klimstra LS Finn JH Lee CJ Yeo JL Cameron RH Hruban 2001 Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p Am J Pathol 159 1619 1627 (Pubitemid 33062504)
98. MA Eberle R Pfutzer KL Pogue-Geile MP Bronner D Crispin MB Kimmey RH Duerr L Kruglyak DC Whitcomb TA Brentnall 2002 A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34 Am J Hum Genet 70 1044 1048 (Pubitemid 34259323)
99. KL Pogue-Geile R Chen MP Bronner T Crnogorac-Jurcevic KW Moyes S Dowen CA Otey DA Crispin RD George DC Whitcomb TA Brentnall 2006 Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism PLoS Med 3 e516
100. J Earl L Yan LJ Vitone J Risk SJ Kemp C McFaul JP Neoptolemos W Greenhalf R Kress M Sina-Frey SA Hahn H Rieder DK Bartsch 2006 Evaluation of the 4q32-34 locus in European familial pancreatic cancer Cancer Epidemiol Biomarkers Prev 15 1948 1955 (Pubitemid 44664273)
101. AP Klein M de Andrade RH Hruban M Bondy AG Schwartz S Gallinger HT Lynch S Syngal KG Rabe MG Goggins GM Petersen 2007 Linkage analysis of chromosome 4 in families with familial pancreatic cancer Cancer Biol Ther 6 320 323 (Pubitemid 47328296)
102. SN Salaria P Illei R Sharma KM Walter AP Klein JR Eshleman A Maitra R Schulick J Winter MM Ouellette M Goggins R Hruban 2007 Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells Cancer Biol Ther 6 324 328 (Pubitemid 47328297)
103. S Jones RH Hruban M Kamiyama M Borges X Zhang DW Parsons JC Lin E Palmisano K Brune EM Jaffee CA Iacobuzio-Donahue A Maitra G Parmigiani SE Kern VE Velculescu KW Kinzler B Vogelstein JR Eshleman M Goggins AP Klein 2009 Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene Science 324 217
104. EP Slater P Langer E Niemczyk K Strauch J Butler N Habbe JP Neoptolemos W Greenhalf DK Bartsch 2010 PALB2 mutations in European familial pancreatic cancer families Clin Genet 78 490 494
105. Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, Amundadottir L, Boutron-Ruault MC, Buring JE, Canzian F, Clipp S, Dorronsoro M, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Jacobs KB, Jenab M, Kraft P, Kooperberg C, Lynch SM, Sund M, Mendelsohn JB, Mouw T, Newton CC, Overvad K, Palli D, Peeters PH, Rajkovic A, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu K, Zeleniuch-Jacquotte A. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int J Cancer. 127:1421-8.
106. RE Brand MM Lerch WS Rubinstein JP Neoptolemos DC Whitcomb RH Hruban TA Brentnall HT Lynch MI Canto 2007 Advances in counselling and surveillance of patients at risk for pancreatic cancer Gut 56 1460 1469 (Pubitemid 47517845)
107. ST Chari CL Leibson KG Rabe J Ransom M de Andrade GM Petersen 2005 Probability of pancreatic cancer following diabetes: a population-based study Gastroenterology 129 504 511 (Pubitemid 41096638)
108. T Ingkakul Y Sadakari J Ienaga N Satoh S Takahata M Tanaka 2010 Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas Ann Surg 251 70 75
109. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, Yeo C, Fishman EK, Brune K, Axilbund J, Griffin C, Ali S, Richman J, Jagannath S, Kantsevoy SV, Kalloo AN. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol. 2006;4:766-81 (quiz 665). (Pubitemid 43825802)
110. MB Kimmey MP Bronner DR Byrd TA Brentnall 2002 Screening and surveillance for hereditary pancreatic cancer Gastrointest Endosc 56 S82 S86
111. W Greenhalf JP Neoptolemos 2006 Increasing survival rates of patients with pancreatic cancer by earlier identification Nat Clin Pract Oncol 3 346 347 (Pubitemid 44027285)
112. H Matsubayashi M Canto N Sato A Klein T Abe K Yamashita CJ Yeo A Kalloo R Hruban M Goggins 2006 DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease Cancer Res 66 1208 1217 (Pubitemid 43165992)
113. L Yan C McFaul N Howes J Leslie G Lancaster T Wong J Threadgold J Evans I Gilmore H Smart M Lombard J Neoptolemos W Greenhalf 2005 Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups Gastroenterology 128 2124 2130 (Pubitemid 40824719)
114. TA Brentnall MP Bronner DR Byrd RC Haggitt MB Kimmey 1999 Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer Ann Intern Med 131 247 255 (Pubitemid 29383653)
115. M Goggins M Canto R Hruban 2000 Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol 74 243 248 (Pubitemid 30660812)
116. W Kimura H Nagai A Kuroda T Muto Y Esaki 1995 Analysis of small cystic lesions of the pancreas Int J Pancreatol 18 197 206 (Pubitemid 26023501)
117. B Davis AM Lowy 2000 Surgical management of hereditary pancreatic cancer Med Clin North Am 84 749 759 (Pubitemid 30346168)